May 2026 • PharmaTimes Magazine • 4-5

Contents

Features

Patients are missing strategy – pharma must seize the day

From listening to action – turning medical insights into patient impact

How AI has strengthened scalability across mid-sized pharma

Who’s really in charge in the NHS? Navigating a disrupted system

Modernisation need in clinical data analysis and regulatory submission

Analysis

GLP-1 drugs – why faster progress won’t fix pharma’s challenges

Why is pharma determined to give AI to patients and HCPs?

Could seven-day timelines could be obsolete by 2028?

Counting the cost of pharma’s change management burden

SmartPeople

14.
Pharma chameleon
Digital maturity gap – how AI is reshaping pharma operations

20.
Real time
Making partnership working business as usual

24.
Kylie’s greatest hits
Building trust with patient organisations – Jess is back

36.
Starting over
There some cool new folk in town and they mean business

0
Logo

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com
https://pharmatimes.com/
Privacy Policy
Terms of Service

Categories

Explore our inspiring content by topic

PharmaTimes
News
Features
Analysis
SmartPeople

Social Footprints

Follow us on our Social Media Channels

X
linkedin